BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25603874)

  • 1. [Interaction between microRNAs and OCT4].
    Chen C; Meng F; Wan H; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):55-8. PubMed ID: 25603874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation.
    Tay Y; Zhang J; Thomson AM; Lim B; Rigoutsos I
    Nature; 2008 Oct; 455(7216):1124-8. PubMed ID: 18806776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate Receptor Alpha Upregulates Oct4, Sox2 and Klf4 and Downregulates miR-138 and miR-let-7 in Cranial Neural Crest Cells.
    Mohanty V; Shah A; Allender E; Siddiqui MR; Monick S; Ichi S; Mania-Farnell B; G McLone D; Tomita T; Mayanil CS
    Stem Cells; 2016 Nov; 34(11):2721-2732. PubMed ID: 27300003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness.
    Lee SH; Chen TY; Dhar SS; Gu B; Chen K; Kim YZ; Li W; Lee MG
    Nucleic Acids Res; 2016 Dec; 44(22):10603-10618. PubMed ID: 27625395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.
    Wang Y; Xu Z; Jiang J; Xu C; Kang J; Xiao L; Wu M; Xiong J; Guo X; Liu H
    Dev Cell; 2013 Apr; 25(1):69-80. PubMed ID: 23541921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis.
    Keshavarz M; Asadi MH
    FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA regulates OCT4 expression in breast cancer cells.
    Kuang WB; -C Deng Q; Deng CT; Li WS; Zhang YG; Shu SW; Zhou MR
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1351-1357. PubMed ID: 29565493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer.
    Fujii T; Shimada K; Tatsumi Y; Fujimoto K; Konishi N
    Biochem Biophys Res Commun; 2015 Jan; 456(1):183-9. PubMed ID: 25462564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells.
    Liu H; Deng S; Zhao Z; Zhang H; Xiao J; Song W; Gao F; Guan Y
    Mol Biol Rep; 2011 Mar; 38(3):2155-60. PubMed ID: 20857206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core transcriptional regulatory circuitry in human embryonic stem cells.
    Boyer LA; Lee TI; Cole MF; Johnstone SE; Levine SS; Zucker JP; Guenther MG; Kumar RM; Murray HL; Jenner RG; Gifford DK; Melton DA; Jaenisch R; Young RA
    Cell; 2005 Sep; 122(6):947-56. PubMed ID: 16153702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
    Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
    Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
    du Puy L; Lopes SM; Haagsman HP; Roelen BA
    Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.